37,164 dead in three years on India's highways, and nobody wants to ask the question that actually matters.
The Ministry of Road Transport and Highways released a stark number in 2024: 37,164 deaths across 6,358 "black corridor" stretches of National Highways between 2021 and 2023. These are not random accidents. These are concentrated zones of death — predictable, mappable, preventable.
The response? More signboards. Better road markings. Speed cameras. Fines for traffic violations. All of it treating the symptom while ignoring the disease. The government is asking how fast the car was going. I am asking how fast the driver's reflexes were working. And that is where the conversation breaks down — because the answer implicates every plate of food served in India for the last two decades.
India is experiencing a silent epidemic of metabolic collapse. We have 101 million diabetics, 135 million with hypertension, and millions more walking around with undiagnosed thyroid disease, chronic acidity, and systemic inflammation. These are not separate problems from highway deaths. These are the same problem wearing different masks.
A driver with uncontrolled blood sugar has delayed reaction time. A man on three blood pressure medications has dizziness and brain fog. A woman with undiagnosed thyroid disease cannot maintain focus for more than 30 minutes. None of these people should be behind a wheel. But they are. Because nobody told them their disease started not in the hospital — but in their gut, three years before the crash happened.
The "black corridors" are not black because of road design. They are black because of the biology of the drivers. Fix the driver, you fix the corridor.
Here is what the pharma industry does not want you to understand: a sick population is a profitable population. The man who develops diabetes at 45 is now a customer for life. Not life as in years remaining — life as in pharmaceutical revenue. Metformin, insulin, statins, antihypertensives, antidepressants. Each drug creates downstream demand for three more drugs to manage side effects.
But a dead driver generates a different kind of revenue. The crash victim goes to the hospital. ICU beds, emergency surgery, antibiotics, painkillers, morphine, sedatives. Then rehabilitation, physiotherapy, more drugs. The family buys a new car. Insurance companies recalibrate premiums. Hospitals expand wings. The economy of death is built into the system.
Nobody is incentivized to ask: Why was this person sick enough to crash in the first place?
First — your chronic disease did not start at the doctor's office. It started years earlier in your choices. High acidity, inflammation, parasitic load, toxin accumulation. These are not diagnoses. These are states of poisoning. You cannot medicate your way out of a poisoning. You have to stop poisoning yourself.
Second — your reflexes, your focus, your reaction time are a direct output of your metabolic health. If you are on medications that suppress symptoms without addressing root cause, you are functionally compromised. Whether you drive or not, you are operating at 70 percent capacity. The highway is just where it becomes visible.
Third — if you have chronic disease, you have a responsibility to reverse it. Not manage it. Not accept it. Reverse it. Through natural healing, through root cause elimination, through the restoration of what your body knew how to do before the pharmaceutical model convinced you that your pancreas was broken forever.
The 37,164 dead are telling us something. Listen.
Follow BHARAT DECODED on Telegram: t.me/DecodedByRDS — Rajnish Sharma (RDS)
Follow Bharat Decoded — India intelligence, RDS Scalar Health, MSME & CosmoAstro decoded daily.
Join Free Health Class WhatsApp Community
About the Author
IIT Delhi M.Tech · 35-year manufacturing industry veteran · Graphene scientist · Hoshiarpur, Punjab. Founder of RDS Scalar Revolution (drug-free self-health education), MSME Turnaround Specialist, and Vedic Astrology practitioner. Author of 90 Secret Number health protocols and the 90-Day Revenue Engine for Indian manufacturers.